We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-4.26%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.9B
AUM Growth
-$1.2B
Cap. Flow
-$334M
Cap. Flow %
-2.11%
Top 10 Hldgs %
20.24%
Holding
1,417
New
118
Increased
414
Reduced
584
Closed
141

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$49.8M
2
WBD icon
Warner Bros
WBD
+$47.5M
3
PYPL icon
PayPal
PYPL
+$41.8M
4
GPC icon
Genuine Parts
GPC
+$39.6M
5
MOS icon
The Mosaic Company
MOS
+$38.4M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$59M
2
TGT icon
Target
TGT
+$55.8M
3
AMAT icon
Applied Materials
AMAT
+$51.1M
4
IT icon
Gartner
IT
+$49.5M
5
NVDA icon
NVIDIA
NVDA
+$38.9M

Sector Composition

Rank Sector Weight
1 Technology 20.54%
2 Healthcare 14.44%
3 Financials 10.72%
4 Consumer Discretionary 8.82%
5 Industrials 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APO icon
1076
Apollo Global Management
APO
$70B
$211K ﹤0.01%
4,547
-20
-0.4% -$1.1K
VERX icon
1077
Vertex
VERX
$2.19B
$210K ﹤0.01%
15,370
-190
-1% -$2.41K
NRC icon
1078
NRC Health Common Stock
NRC
$416M
$209K ﹤0.01%
5,260
-635
-11% -$23.5K
FATE icon
1079
Fate Therapeutics
FATE
$272M
$207K ﹤0.01%
+9,245
New +$267K
IYF icon
1080
iShares US Financials ETF
IYF
$4.68B
$207K ﹤0.01%
3,072
XRAY icon
1081
Dentsply Sirona
XRAY
$2.82B
$207K ﹤0.01%
+7,310
New +$250K
TAK icon
1082
Takeda Pharmaceutical
TAK
$56.7B
$206K ﹤0.01%
15,954
-382
-2% -$5.31K
UBS icon
1083
UBS Group
UBS
$171B
$206K ﹤0.01%
14,234
-358
-2% -$5.73K
GAP
1084
The Gap Inc
GAP
$7.28B
$206K ﹤0.01%
25,128
+5,589
+29% +$52.4K
AEIS icon
1085
Advanced Energy
AEIS
$10.4B
$205K ﹤0.01%
+2,656
New +$228K
CC icon
1086
Chemours
CC
$2.5B
$204K ﹤0.01%
8,298
+818
+11% +$27K
CZR icon
1087
Caesars Entertainment
CZR
$6.06B
$203K ﹤0.01%
+6,321
New +$275K
FWONK icon
1088
Liberty Media Series C
FWONK
$25.4B
$199K ﹤0.01%
3,528
-547
-13% -$33.8K
INDY icon
1089
iShares S&P India Nifty 50 Index Fund
INDY
$559M
$197K ﹤0.01%
4,668
MOO icon
1090
VanEck Agribusiness ETF
MOO
$993M
$197K ﹤0.01%
2,452
IVZ icon
1091
Invesco
IVZ
$12.5B
$194K ﹤0.01%
14,252
-3,416
-19% -$57.6K
NCLH icon
1092
Norwegian Cruise Line
NCLH
$9.56B
$193K ﹤0.01%
+17,003
New +$224K
SIRI icon
1093
SiriusXM
SIRI
$10.8B
$193K ﹤0.01%
3,394
+1,674
+97% +$105K
USRT icon
1094
iShares Core US REIT ETF
USRT
$4.73B
$191K ﹤0.01%
4,024
IEV icon
1095
iShares Europe ETF
IEV
$1.64B
$188K ﹤0.01%
5,000
ETNB
1096
DELISTED
89bio
ETNB
$187K ﹤0.01%
32,338
CCL icon
1097
Carnival Corporation Ltd
CCL
$38.1B
$186K ﹤0.01%
+26,554
New +$257K
PHYS icon
1098
Sprott Physical Gold
PHYS
$14.6B
$185K ﹤0.01%
14,550
-6,830
-32% -$91.9K
HEDJ icon
1099
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.82B
$177K ﹤0.01%
5,706
XOP icon
1100
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.52B
$176K ﹤0.01%
1,413

Similar funds

Glenmede Trust's Q3 2022 Portfolio in Review

As of Q3 2022, Glenmede Trust held 1,417 positions worth $15.9B, down 7% from $17.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Glenmede Trust's Q3 2022 filing shows 118 new, 414 increased, 584 reduced and 141 closed positions. Its largest new stake was Privia Health: 119,083 shares worth $4.05M. The largest sale was Meta Platforms (Facebook), an estimated $59M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2022 buy was Privia Health: 119,083 shares worth $4.05M.
  • Glenmede Trust added most to Kellanova in Q3 2022, an estimated $49.8M increase.
  • Glenmede Trust's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $59M.
  • Glenmede Trust fully exited Atlas Air Worldwide Holdings, Inc. in Q3 2022, selling an estimated $15.5M.
  • Glenmede Trust's ten largest holdings make up 20% of its $15.9B portfolio in Q3 2022.
  • Glenmede Trust opened 118 new positions and closed 141 in Q3 2022.
  • Glenmede Trust's portfolio value fell 7% quarter-over-quarter to $15.9B.

Based on Glenmede Trust's 13F filing for Q3 2022, filed 16 Nov 2022.